- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Novel treatment paradigms for metastatic uveal melanoma ; volume:29 ; number:12 ; day:1 ; month:12 ; year:2022 ; pages:1807-1808 ; date:12.2022
Cancer gene therapy ; 29, Heft 12 (1.12.2022), 1807-1808, 12.2022
- Creator
-
Patel, Sapna P.
Katz, Steven C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41417-022-00558-y
- URN
-
urn:nbn:de:101:1-2023021721104040893940
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.0009, 10:00 AM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Patel, Sapna P.
- Katz, Steven C.
- SpringerLink (Online service)
Other Objects (12)
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Clinical determinants of long-term survival in metastatic uveal melanoma
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
The Current State of Systemic Therapy of Metastatic Uveal Melanoma
Clinical determinants of long-term survival in metastatic uveal melanoma
Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk
The immune cell landscape of metastatic uveal melanoma correlates with overall survival
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Clinical determinants of long-term survival in metastatic uveal melanoma
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
The Current State of Systemic Therapy of Metastatic Uveal Melanoma
Clinical determinants of long-term survival in metastatic uveal melanoma
Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk
The immune cell landscape of metastatic uveal melanoma correlates with overall survival
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Clinical determinants of long-term survival in metastatic uveal melanoma
Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis
The Current State of Systemic Therapy of Metastatic Uveal Melanoma
Clinical determinants of long-term survival in metastatic uveal melanoma
Presumed Melanoma of Unknown Primary Origin Metastatic to the Choroid Mimics Primary Uveal Melanoma
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk
The immune cell landscape of metastatic uveal melanoma correlates with overall survival